TRICCAR Holdings, Inc. is a vertically integrated pioneer in bioceutical development. Our proprietary Hypothesis-based Rapid Prototyping, combined with a focus on natural ingredients and proprietary extraction processes, has led to 38 successful treatments developed and tested to date with 6 more in development, including a potential solution to glyphosate poisoning and a non-agricultural means to replicate cannabinoids (CBD) in mass quantities without the need to grow and cultivate hemp. The market for our human and animal science products is $1 trillion.
TRICCAR Holdings, Inc. is a privately-held company based in Las Vegas, Nevada with additional offices in Hampton, Virginia and Mesa, Arizona. We plan to open our Beijing, China office in early-2019 and United Kingdom and Dubai, United Arab Emirates offices--in conjunction with partners--thereafter.
TRICCAR has one of the most diverse senior management teams in our industry, with 6 of our 12 (50%) executives being minorities/women.
Our founder, Bill Townsend, was part of the founding/senior management teams at companies like Ketchum, Lycos, GeoCities (sold to Yahoo!), Deja.com (sold to Google and ebay), sixdegrees (the intellectual property behind LinkedIn), with exits over $9 billion. When creating TRICCAR, he pulled together great talent that has each been touched by health issues in their families.
Our chairman, Ron Howell, is CEO and owner of a nutraceutical direct sales company selling dozens of products through 200,000 distributors worldwide.
Our CFO, Katrina Yao, is a CPA, Certified Internal Auditor, and Certified Information System Auditor with a superior track record, including as head of global finance of $2.8 billion retailer newegg.com.
Our VP, Nutrition, David Yang, spent 17 years at Procter and Gamble developing nutritional products. He holds 12 patents.
Our VP, Product Management, Chuck Gagel, spent 30+ years at P&G, mostly in creating and clinical testing of products, with significant experience in sports nutrition.
TRICCAR's VP, DOJ/DEA Relations, William Simpson, Jr., spent 32 years and retired from the United States Drug Enforcement Administration as Chief of Operations Management Worldwide.
Last, but not least, our VP, University & Medical Partnerships, Deborah Taylor, was formerly Executive Director at the University of Kentucky.
The team is rounded out by Dianna Ritchie, VP of Human Resources; Brian Kalinowski, SVP of Sales & Marketing; and Robert Cudlip, VP of Digital Marketing.
TRICCAR's Scientific Advisory Board includes world class physicians and researchers, including:
Dr. Timothy Charlton, a leading foot and ankle specialist at Cedars-Sinai Medical Center in Los Angeles. He is a graduate of Columbia University College of Physicians and Surgeons and a member of the American Board of Orthopaedic Surgeons and the American Academy of Orthopaedic Surgeons.
Dr. Thomas Tobin, MVB, MSc, PhD, MRCVS, AMAORC,is a research PhD specializing in Pharmacology at the University of Kentucky. He is the author of over 300 papers and inventor of the ELISA test. His congenital toxoplasmosis patent was licensed to Bayer Animal Science, which was turned into a $100M product.
Dr. Alden Townsend is a plant geneticist who spent much of his career at the United States National Arboretum. He has published more than 100 scientific and popular works. He earned his B.S. in Forest Science from Penn State University, an M.F. in genetics and ecology from Yale and a Ph.D. in forest genetics and plant breeding from Michigan State University.
Dr. Yossi Tam is Head of Obesity and Metabolism Laboratory, and Director Multidisciplinary Center for Cannabinoid Research at The Hebrew University of Jerusalem. He is widely considered one of the world’s foremost cannabinoids researchers.
Dr. Jonathan Kanevsky graduated with top honors from McGill University Faculty of Medicine and is an expert on Artificial Intelligence in health care. He was awarded The Charles E. FrosstMedical Prize and is the recipient of The Plastic Surgery Foundation Innovation Award.
Dr. Stefanie Tan is an internist specializing in diabetes. She is a faculty physician at the Internal Medicine Center of Summa Health System in Akron, Ohio.
Dr. Gregory Vassilev is a board-certified anesthesiologist and an interventional pain management specialist whose specializes in the management of complex pain, joint rejuvenation, and addiction medicine. He is a graduate of the David Geffen School of Medicine at UCLA.
Many of our team members have worked together in past companies and all are connected by the desire to provide effective, low cost treatments to provide hope for a better tomorrow.
Our Series B financial round is represented by:
Black Legend Capital
12121 Wilshire Blvd., Ste. 725
Los Angeles, California 90025
If you have a Username and Password, click here to watch a 20-minute presentation on our business. To request a password, please us the Contact link below.
Want to learn more about TRICCAR and the amazing discoveries we've made? Want to request a Username and Password to the Video Presentation? Click below.
Copyright © 2018 TRICCAR Holdings, Inc. - All Rights Reserved.
No part of this site may be reproduced without written permission.
Note about information contained on this website: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.